Literature DB >> 3338609

Symptomatology of ovarian cancer.

F Flam1, N Einhorn, K Sjövall.   

Abstract

The symptomatology of ovarian cancer was retrospectively reviewed in 362 patients. According to the stage at diagnosis, the disease was classified as early (stages IA-IIA) or advanced (stages IIB-IV). The most common initial symptoms were abdominal swelling and/or palpable tumour, pain and gastro-intestinal symptoms. The initial symptoms, however, were not necessarily those that prompted the patients to seek medical advice. Most were first seen by a gynecologist, which possibly explains the shortness of doctor's delay in the urbanized catchment region.

Entities:  

Mesh:

Year:  1988        PMID: 3338609     DOI: 10.1016/s0028-2243(88)80010-8

Source DB:  PubMed          Journal:  Eur J Obstet Gynecol Reprod Biol        ISSN: 0301-2115            Impact factor:   2.435


  7 in total

Review 1.  Management of gynaecological cancers.

Authors:  A Melville; A Eastwood; J Kleijnen; H Kitchener; P Martin-Hirsch; L Nelson
Journal:  Qual Health Care       Date:  1999-12

2.  The anti-adhesive mucin podocalyxin may help initiate the transperitoneal metastasis of high grade serous ovarian carcinoma.

Authors:  Jane A Cipollone; Marcia L Graves; Martin Köbel; Steve E Kalloger; Tak Poon; C Blake Gilks; Kelly M McNagny; Calvin D Roskelley
Journal:  Clin Exp Metastasis       Date:  2012-01-20       Impact factor: 5.150

3.  Effect of delays in primary care referral on survival of women with epithelial ovarian cancer: retrospective audit.

Authors:  John M J Kirwan; Douglas G Tincello; Jonathan J O Herod; Olive Frost; Robert E Kingston
Journal:  BMJ       Date:  2002-01-19

4.  Epithelial ovarian cancer. Risk factors, screening and the role of prophylactic oophorectomy.

Authors:  A Daniilidis; V Karagiannis
Journal:  Hippokratia       Date:  2007-04       Impact factor: 0.471

5.  Prediagnostic symptoms of ovarian carcinoma: a case-control study.

Authors:  Galina Lurie; Pamela J Thompson; Katharine E McDuffie; Michael E Carney; Marc T Goodman
Journal:  Gynecol Oncol       Date:  2009-05-22       Impact factor: 5.482

6.  Time to diagnosis of Type I or II invasive epithelial ovarian cancers: a multicentre observational study using patient questionnaire and primary care records.

Authors:  Aww Lim; D Mesher; A Gentry-Maharaj; N Balogun; M Widschwendter; I Jacobs; P Sasieni; U Menon
Journal:  BJOG       Date:  2015-05-29       Impact factor: 6.531

7.  Wnt/β-catenin pathway as a potential prognostic and predictive marker in patients with advanced ovarian cancer.

Authors:  Lubomir Bodnar; Aleksandra Stanczak; Szczepan Cierniak; Marta Smoter; Marzena Cichowicz; Wojciech Kozlowski; Cezary Szczylik; Maciej Wieczorek; Monika Lamparska-Przybysz
Journal:  J Ovarian Res       Date:  2014-02-06       Impact factor: 4.234

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.